Jim Deng is currently the Senior Director of Business Development and Strategy at Third Harmonic Bio, having begun this role in 2024. Previously, they served as the Senior Director of Corporate Strategy and New Product Planning at Ocelot Bio from 2022 to 2024 and held the position of Director of Commercial Strategy at BridgeBio from 2021 to 2022. Jim also gained experience as a Manager at Clarion, a Life Sciences Consultancy, from 2013 to 2021, and worked as a Research Assistant at the International Consortium for Health Outcomes Measurement in 2013. They began their professional journey with a summer analyst position at Pelagos Capital Management in 2012 and were a research intern at the Yale University Department of Molecular Cellular and Developmental Biology in 2010. Jim is currently pursuing a BA in Human Evolutionary Biology with a secondary concentration in Music at Harvard University.
This person is not in any teams
This person is not in any offices